These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36344675)

  • 1. Identification of a novel GR-ARID1a-P53BP1 protein complex involved in DNA damage repair and cell cycle regulation.
    Stubbs FE; Flynn BP; Rivers CA; Birnie MT; Herman A; Swinstead EE; Baek S; Fang H; Temple J; Carroll JS; Hager GL; Lightman SL; Conway-Campbell BL
    Oncogene; 2022 Dec; 41(50):5347-5360. PubMed ID: 36344675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SKOV3 cells containing a truncated ARID1a protein have a restricted genome-wide response to glucocorticoids.
    Stubbs FE; Birnie MT; Biddie SC; Lightman SL; Conway-Campbell BL
    Mol Cell Endocrinol; 2018 Feb; 461():226-235. PubMed ID: 28942102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response.
    Mandal J; Mandal P; Wang TL; Shih IM
    J Biomed Sci; 2022 Sep; 29(1):71. PubMed ID: 36123603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.
    Kelso TWR; Porter DK; Amaral ML; Shokhirev MN; Benner C; Hargreaves DC
    Elife; 2017 Oct; 6():. PubMed ID: 28967863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response.
    Bakr A; Della Corte G; Veselinov O; Kelekçi S; Chen MM; Lin YY; Sigismondo G; Iacovone M; Cross A; Syed R; Jeong Y; Sollier E; Liu CS; Lutsik P; Krijgsveld J; Weichenhan D; Plass C; Popanda O; Schmezer P
    Nucleic Acids Res; 2024 Jun; 52(10):5698-5719. PubMed ID: 38587186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting ARID1A-mutant colorectal cancer: depletion of ARID1B increases radiosensitivity and modulates DNA damage response.
    Niedermaier B; Sak A; Zernickel E; Xu S; Groneberg M; Stuschke M
    Sci Rep; 2019 Dec; 9(1):18207. PubMed ID: 31796878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy.
    Park Y; Chui MH; Suryo Rahmanto Y; Yu ZC; Shamanna RA; Bellani MA; Gaillard S; Ayhan A; Viswanathan A; Seidman MM; Franco S; Leung AKL; Bohr VA; Shih IM; Wang TL
    Clin Cancer Res; 2019 Sep; 25(18):5584-5594. PubMed ID: 31196855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update.
    Banerjee S; Roy S
    Cell Cycle; 2021 Sep; 20(18):1760-1784. PubMed ID: 34437813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting ARID1A mutations in cancer.
    Mullen J; Kato S; Sicklick JK; Kurzrock R
    Cancer Treat Rev; 2021 Nov; 100():102287. PubMed ID: 34619527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice.
    Kartha N; Shen L; Maskin C; Wallace M; Schimenti JC
    Genetics; 2016 Aug; 203(4):1601-11. PubMed ID: 27280691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.
    Watanabe R; Ui A; Kanno S; Ogiwara H; Nagase T; Kohno T; Yasui A
    Cancer Res; 2014 May; 74(9):2465-75. PubMed ID: 24788099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcriptional histone acetyltransferase cofactor TRRAP associates with the MRN repair complex and plays a role in DNA double-strand break repair.
    Robert F; Hardy S; Nagy Z; Baldeyron C; Murr R; Déry U; Masson JY; Papadopoulo D; Herceg Z; Tora L
    Mol Cell Biol; 2006 Jan; 26(2):402-12. PubMed ID: 16382133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tumor Suppressor ARID1A Controls Global Transcription via Pausing of RNA Polymerase II.
    Trizzino M; Barbieri E; Petracovici A; Wu S; Welsh SA; Owens TA; Licciulli S; Zhang R; Gardini A
    Cell Rep; 2018 Jun; 23(13):3933-3945. PubMed ID: 29949775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARID1A-dependent maintenance of H3.3 is required for repressive CHD4-ZMYND8 chromatin interactions at super-enhancers.
    Reske JJ; Wilson MR; Armistead B; Harkins S; Perez C; Hrit J; Adams M; Rothbart SB; Missmer SA; Fazleabas AT; Chandler RL
    BMC Biol; 2022 Sep; 20(1):209. PubMed ID: 36153585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARID1A loss in cancer: Towards a mechanistic understanding.
    Mathur R
    Pharmacol Ther; 2018 Oct; 190():15-23. PubMed ID: 29730444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of the AT-Rich Interaction Domain 1A Gene (
    Li JJ; Lee CS
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38275587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.
    Guan B; Wang TL; Shih IeM
    Cancer Res; 2011 Nov; 71(21):6718-27. PubMed ID: 21900401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes.
    Raab JR; Resnick S; Magnuson T
    PLoS Genet; 2015 Dec; 11(12):e1005748. PubMed ID: 26716708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARID1A-mutated ovarian cancers depend on HDAC6 activity.
    Bitler BG; Wu S; Park PH; Hai Y; Aird KM; Wang Y; Zhai Y; Kossenkov AV; Vara-Ailor A; Rauscher FJ; Zou W; Speicher DW; Huntsman DG; Conejo-Garcia JR; Cho KR; Christianson DW; Zhang R
    Nat Cell Biol; 2017 Aug; 19(8):962-973. PubMed ID: 28737768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.